Close Menu


The company is working to develop another lab-based serology test to detect IgM antibodies in people who have already had the virus.

The test is a probe-based reverse transcription PCR test for detecting the coronavirus by targeting conserved regions of its genome.

Though its overall diagnostics revenues fell year over year, its molecular diagnostics business had a strong quarter with sales growth of 29 percent.

The new rate applies to clinical diagnostic lab tests using high-throughput technologies that can process more than 200 specimens per day.

The Project Screen initiative aims to provide the Hong Kong community with home access to the World Health Organization-approved RT-PCR test for SARS-CoV-2 at zero profit to its organizers.

Use of the assay by Finland's main clinical laboratories will double testing capacity and allow test coverage for most of the country, Mobidiag said.

Seegene said Monday that the Health Canada approval will enable hospitals and licensed labs there to run the assay immediately for high-volume testing.

The company's qualitative real-time PCR test detects SARS-CoV-2 from nasal, nasopharyngeal, and oropharyngeal swabs.

The molecular laboratory-developed test was authorized for use only in the Stanford Health Care Clinical Virology Laboratory.

The company said it has recently expanded its manufacturing capacity to 500,000 tests per week and is planning to increase it another fourfold.